TORONTO, Nov. 2 /CNW/ - Lorus Therapeutics Inc. ('Lorus'), a
biopharmaceutical company specializing in the development and
commercialization of pharmaceutical products and technologies for the
management of cancer, today announced the reduction of staff by approximately
35%.
